United Front Intl
No Result
View All Result
Sunday, May 28, 2023
  • Login
  • Register
  • Home
  • US
  • World
  • Politics
  • Coronavirus
  • Videos
  • Be in the Know
  • ShopNew
Contact us
United Front Intl
  • Home
  • US
  • World
  • Politics
  • Coronavirus
  • Videos
  • Be in the Know
  • ShopNew

No products in the cart.

No Result
View All Result
United Front Intl
No Result
View All Result
Home Coronavirus

S.Korea secures 20,000 courses of Merck’s COVID-19 pill, says PM

by admin
October 6, 2021
in Be in the Know, Coronavirus
S.Korea secures 20,000 courses of Merck’s COVID-19 pill, says PM

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid

Share on FacebookShare on Twitter

Reuters
By Sangmi Cha

SEOUL, Oct 6 (Reuters) – South Korea has secured 20,000 courses of an experimental antiviral pill developed by Merck & Co (MRK.N) for COVID-19 treatment, Prime Minister Kim Boo-kyum said on Wednesday, joining other Asian nations rushing to snap up supplies.

Merck also announced on Wednesday a supply and purchase agreement with Singapore, following Australia, while Thailand, Taiwan and Malaysia said they are in talks to buy it.

Molnupiravir, on its way to be the first oral antiviral medication for COVID-19, could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19. Merck is seeking approval by the U.S. Food and Drug Administration for the pill.

The course of treatment involves patients taking four pills twice daily for five days.

“We already have secured a budget enough for treatment of around 40,000 people and have signed a pre-purchase deal for 20,000 courses,” Kim told a COVID-19 response meeting on Wednesday.

South Korea is also looking to buy other antiviral drugs, he said.

Merck said it plans a tiered pricing approach based on country income criteria. The U.S. government has a contract to buy 1.7 million courses at a price of $700 per course.

The Korea Disease Control and Prevention Agency (KDCA) had said it was also in talks with Pfizer (PFE.N) and Swiss drugmaker Roche Holding AG (ROG.S), who are also racing to develop an easy-to-administer antiviral pill for COVID-19.

South Korean government had allocated 36.2 billion won ($30.31 million) in budget for oral antiviral pills to cure COVID-19. It has been managing its mortality rate – 0.78% as of Tuesday – and critical cases at a fairly low rate.

($1 = 1,194.2300 won)

Reporting by Sangmi Cha; Editing by Simon Cameron-Moore

Related

ShareTweetSendSend

Related Posts

At least 19 confirmed dead in Mahdia school dorm fire
World

At least 19 confirmed dead in Mahdia school dorm fire

May 22, 2023
The Coronation of King Charles III and Queen Camilla
Be in the Know

The Coronation of King Charles III and Queen Camilla

May 8, 2023
International Women of Courage Award Ceremony hosted by Dr. Jill Biden
Videos

International Women of Courage Award Ceremony hosted by Dr. Jill Biden

March 14, 2023
Ghana winger Atsu’s body found under rubble in Turkey
Be in the Know

Ghana winger Atsu’s body found under rubble in Turkey

February 18, 2023
The border buses: New York City’s migrant crisis | States of America
Videos

The border buses: New York City’s migrant crisis | States of America

January 30, 2023
What is known about new Covid variant XBB.1.5?
Coronavirus

What is known about new Covid variant XBB.1.5?

January 17, 2023

My Cart

At least 19 confirmed dead in Mahdia school dorm fire
World

At least 19 confirmed dead in Mahdia school dorm fire

by admin
May 22, 2023

Categories

  • Be in the Know
  • Coronavirus
  • Politics
  • US
  • Videos
  • World

UnitedFrontIntl Store

My Account & Ordering
Cart
Checkout
Track My Order
Refund and Returns Policy
Privacy Policy
FAQs

Site Navigation

  • Home
  • Advertise
  • Contact Us
  • Jobs
  • About Us
  • Shipping Policy

Links

CNBC
Reuters

The New York Times
The Washington Post


Your tax-deductible gift is vital and will help us fund and maintain our website to bring you current news and information on a daily basis. Thank you in advance.

© 2022 United Front Intl

No Result
View All Result
  • Home
  • US
  • World
  • Politics
  • Coronavirus
  • Videos
  • Be in the Know
  • Contact Us
  • Advertisement
  • Shop

© 2022 United Front Intl

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In